Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07645573 · ClinicalTrials.gov registry record · Early Phase 1
18f-ftha Imaging OF THE Intestinal AND Central Lymphatic System
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT07645573: Recruiting Early Phase 1 study, sponsored by University of Pennsylvania.
NCT07645573 is a Early Phase 1 study that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07645573, a Early Phase 1 study, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The project will be performed over a period of approximately two years. In the first year the \[18F\]FTHA tracer will be developed, optimized, and tested on normal volunteers. During the second year, the tracer will be investigated on patients with suspected obstruction of the thoracic duct (TD).
Interventions
- DIAGNOSTIC_TEST [18F]FTHA PET/CT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-10 |
| Est. Completion | 2029-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07645573
The ClinicalTrials.gov registry entry for NCT07645573 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]FTHA PET/CT scan is the first listed.
NCT07645573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07645573 about?
NCT07645573 is a clinical study titled "18f-ftha Imaging OF THE Intestinal AND Central Lymphatic System". The project will be performed over a period of approximately two years. In the first year the \[18F\]FTHA tracer will be developed, optimized, and tested on normal volunteers. During the second year, the tracer will be investigated on patients with suspected obstruction of the thoracic duct (TD).
What is the current status of trial NCT07645573?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2025-10-10. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07645573?
The interventions under investigation include: [18F]FTHA PET/CT scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07645573?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.